Search Results 1131-1140 of 19033 for Neutrophil

  1. Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count ≥ 100,000/mm^3; Hemoglobin > 9.0 g/dL; Total serum bilirubin ≤ 2 mg/dL; Aspartate transaminase ...

  2. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN OR direct bilirubin ≤ ULN;; Alanine ...

  3. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

    Clinically significant anemia (hemoglobin < 8 g/dL), neutropenia (absolute neutrophil count [ANC] < 1000/mm3) or thrombocytopenia (platelets < 50,000/mm^3) ...

  4. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) >= 1500/mm^3; Platelet count >= 100,000/mm^3; Hemoglobin > 9.0 g/dL; Total bilirubin =< 1.5 x upper limit of normal (ULN); if ...

  5. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 750 cells/μL (0.75 x 10^9 /L) or ≥ 500 cells/μL (0.50 x 10^9 /L) in subjects with documented bone marrow involvement and ...

  6. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

    Participation eligibility · Absolute neutrophil count ≥ 1.5 × 10^9 /L; · Platelet count ≥ 100 × 10^9 /L; subjects with stable platelet count from 75-100 × 10^9 ...

  7. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Absolute neutrophil count ≥ 1.5 x 10^9/L;; Platelets ≥ 100 x 10^9/L - Albumin ≥ 2.5 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN);; Aspartate ...

  8. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    * Absolute neutrophil count (ANC) \>= 1500/mm\^3 (less than or equal to 28 days prior to registration) * Platelet count \>= 75,000/mm\^3 (less than or equal ...

  9. Publications - Eva M. Carmona Porquera, M.D., Ph.D. - Mayo Clinic

    ... Neutrophil Chemotaxis. J Immunol. 2015 Dec 1; 195 (11):5318-26 Epub 2015 Oct 30. View PubMed; Arvelo CL , Carmona EM , Ryu JH . Lung and airway disorders in ...

  10. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1000/uL. Platelet count ≥ 75,000/uL. Absolute lymphocyte count ≥ 100/uL. Adequate renal, hepatic, pulmonary and cardiac ...